News | Cardiovascular Education | March 21, 2024

UCLA Health Selects Dr. Priscilla Hsue as Cardiology Division Chief

The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID. She is currently serving as co-director of the UCSF Center for Excellence in Vascular Research, and is a member of ImmunoX and the Cardiovascular Research Institute.

The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID.

The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID. She is currently serving as co-director of the UCSF Center for Excellence in Vascular Research, and is a member of ImmunoX and the Cardiovascular Research Institute. Image courtesy: UCLA


March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the UCLA Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID. She is currently serving as co-director of the UCSF Center for Excellence in Vascular Research, and is a member of UCSF ImmunoX and the Cardiovascular Research Institute, according to a written statement from UCLA Health announcing the news. Currently, she is the Maurice Eliaser Jr. MD Distinguished Professor of Medicine and Chief of Cardiology, UCSF at Zuckerberg San Francisco General Hospital and Trauma Center.

UCLA Health’s news update also reported that Hsue discovered higher rates of cardiovascular disease in HIV and then elucidated the mechanism underlying this disease process. Her work demonstrated the role of chronic inflammation and immune activation in treated HIV which has been shown to be strongly predictive of clinical events and mortality. As a pioneer of HIV cardiology, her body of work continues to be multidisciplinary, innovative, and paradigm shifting in medicine. Further, the summary noted, her groundbreaking work at UCSF includes clinical trials of anti-inflammatory, immunomodulatory, and lipid-lowering therapies, not only in the context of HIV but also in areas such as rheumatoid arthritis, atherosclerosis, and most recently, COVID-19.

Since 2005, Hsue has been a continuous recipient of NIH funding, serving as principal investigator (PI) and co-investigator (Co-I) on numerous NIH grants. Notably, her extensive contributions to the field are reflected in publications in prestigious journals, including the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, JAMA Cardiology, Clinical Infectious Diseases, and AIDS.

Hsue is an associate program director for research for the UCSF Cardiology Fellowship Program and serves on the admissions committee for the UCSF School of Medicine. She has had the privilege of mentoring numerous students, trainees and faculty, has a 10-year K24 grant for mentoring from the National Institute of Allergy and Infectious Diseases, and has been recognized by multiple mentoring awards during her career. 

Cardiovascular Leadership

Beyond her research, Hsue has played pivotal roles in various advisory and leadership positions, according to the announcement, such as the following:

  • Chair of the Clinical and Integrative Cardiovascular Science and future chair of the Single-Site and Pilot Clinical Trials Study Sections at the National Heart, Lung, and Blood Institute.
  • An elected member and vice president of the American Society of Clinical Investigation (ASCI) and will transition to president in the future.
  • Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC); a member of the Association of University Cardiologists and a member of the Association of American Physicians.
  • Previously served on the Office of AIDS Research Advisory Council at NIH and the Scientific Committee of the Sarnoff Cardiovascular Research Foundation.

Hsue completed her medical degree, internal medicine residency and cardiology fellowship training at UCSF where she has been on faculty since 2002.

More information: www.uclahealth.org


Related Content

Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Feature | Cardiovascular Education | Christine Book

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
News | Cardiovascular Education

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
News | Cardiovascular Education

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac ...

Home April 04, 2023
Home
News | Cardiovascular Education

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

Home March 30, 2023
Home
News | Cardiovascular Education

December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...

Home December 26, 2022
Home
Subscribe Now